Laura A Hart1, Elizabeth A Phelan2, Julia Y Yi3, Zachary A Marcum3, Shelly L Gray3. 1. Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California. 2. Division of Gerontology and Geriatric Medicine, Department of Medicine, and Department of Health Services, School of Public Health, University of Washington, Seattle, Washington. 3. Department of Pharmacy, University of Washington School of Pharmacy, Seattle, Washington.
Abstract
OBJECTIVES: To examine: (1) prevalence of fall risk-increasing drug (FRID) use among older adults with a fall-related injury, (2) which FRIDs were most frequently prescribed, (3) whether FRID use was reduced following the fall-related healthcare episode, and (4) which interventions have reduced falls or FRID use in older adults with a history of falls. DESIGN: Systematic review. PARTICIPANTS: Observational and intervention studies that assessed (or intervened on) FRID use in participants aged 60 years or older who had experienced a fall. MEASUREMENTS: PubMed and EMBASE were searched through June 30, 2019. Two reviewers independently extracted data and evaluated studies for bias. Discrepancies were resolved by consensus. RESULTS: Fourteen of 638 articles met selection criteria: 10 observational studies and 4 intervention studies. FRID use prevalence at time of fall-related injury ranged from 65% to 93%. Antidepressants and sedatives-hypnotics were the most commonly prescribed FRIDs. Of the 10 observational studies, only 2 used a design adequate to capture changes in FRID use after a fall-related injury, neither finding a reduction in FRID use. Three randomized controlled studies conducted in various settings (hospital, emergency department, and community pharmacy) with 12-month follow-up did not find a reduction in falls with interventions to reduce FRID use, although the study conducted in the community pharmacy setting was effective in reducing FRID use. In a nonrandomized (pre-post) intervention study conducted in an outpatient geriatrics clinic, falls were reduced in the intervention group. CONCLUSIONS: Limited evidence indicates high prevalence of FRID use among older adults who have experienced a fall-related injury and no reduction in overall FRID use following the fall-related healthcare encounter. There is a need for well-designed interventions to reduce FRID use and falls in older adults with a history of falls. Reducing FRID use as a stand-alone intervention may not be effective in reducing recurrent falls. J Am Geriatr Soc 68:1334-1343, 2020.
OBJECTIVES: To examine: (1) prevalence of fall risk-increasing drug (FRID) use among older adults with a fall-related injury, (2) which FRIDs were most frequently prescribed, (3) whether FRID use was reduced following the fall-related healthcare episode, and (4) which interventions have reduced falls or FRID use in older adults with a history of falls. DESIGN: Systematic review. PARTICIPANTS: Observational and intervention studies that assessed (or intervened on) FRID use in participants aged 60 years or older who had experienced a fall. MEASUREMENTS: PubMed and EMBASE were searched through June 30, 2019. Two reviewers independently extracted data and evaluated studies for bias. Discrepancies were resolved by consensus. RESULTS: Fourteen of 638 articles met selection criteria: 10 observational studies and 4 intervention studies. FRID use prevalence at time of fall-related injury ranged from 65% to 93%. Antidepressants and sedatives-hypnotics were the most commonly prescribed FRIDs. Of the 10 observational studies, only 2 used a design adequate to capture changes in FRID use after a fall-related injury, neither finding a reduction in FRID use. Three randomized controlled studies conducted in various settings (hospital, emergency department, and community pharmacy) with 12-month follow-up did not find a reduction in falls with interventions to reduce FRID use, although the study conducted in the community pharmacy setting was effective in reducing FRID use. In a nonrandomized (pre-post) intervention study conducted in an outpatient geriatrics clinic, falls were reduced in the intervention group. CONCLUSIONS: Limited evidence indicates high prevalence of FRID use among older adults who have experienced a fall-related injury and no reduction in overall FRID use following the fall-related healthcare encounter. There is a need for well-designed interventions to reduce FRID use and falls in older adults with a history of falls. Reducing FRID use as a stand-alone intervention may not be effective in reducing recurrent falls. J Am Geriatr Soc 68:1334-1343, 2020.
Authors: Nicole D A Boyé; Nathalie van der Velde; Oscar J de Vries; Esther M M van Lieshout; Klaas A Hartholt; Francesco U S Mattace-Raso; Paul Lips; Peter Patka; Ed F van Beeck; Tischa J M van der Cammen Journal: Age Ageing Date: 2017-01-10 Impact factor: 10.668
Authors: Andrea Correa-Pérez; Eva Delgado-Silveira; Sagrario Martín-Aragón; Aurora M Rojo-Sanchís; Alfonso J Cruz-Jentoft Journal: Aging Clin Exp Res Date: 2018-10-01 Impact factor: 3.636
Authors: Sabrina W Pit; Julie E Byles; David A Henry; Lucy Holt; Vibeke Hansen; Deborah A Bowman Journal: Med J Aust Date: 2007-07-02 Impact factor: 7.738
Authors: Julian P T Higgins; Douglas G Altman; Peter C Gøtzsche; Peter Jüni; David Moher; Andrew D Oxman; Jelena Savovic; Kenneth F Schulz; Laura Weeks; Jonathan A C Sterne Journal: BMJ Date: 2011-10-18
Authors: Lesley D Gillespie; M Clare Robertson; William J Gillespie; Catherine Sherrington; Simon Gates; Lindy M Clemson; Sarah E Lamb Journal: Cochrane Database Syst Rev Date: 2012-09-12
Authors: Denis O'Mahony; David O'Sullivan; Stephen Byrne; Marie Noelle O'Connor; Cristin Ryan; Paul Gallagher Journal: Age Ageing Date: 2014-10-16 Impact factor: 10.668
Authors: Laura A Hart; Rod Walker; Elizabeth A Phelan; Zachary A Marcum; Naomi R M Schwartz; Paul K Crane; Eric B Larson; Shelly L Gray Journal: J Am Geriatr Soc Date: 2021-10-19 Impact factor: 5.562
Authors: Sue Jordan; Hayley Prout; Neil Carter; John Dicomidis; Jamie Hayes; Jeffrey Round; Andrew Carson-Stevens Journal: PLoS One Date: 2021-01-07 Impact factor: 3.240
Authors: Birgit A Damoiseaux-Volman; Kimmy Raven; Danielle Sent; Stephanie Medlock; Johannes A Romijn; Ameen Abu-Hanna; Nathalie van der Velde Journal: Age Ageing Date: 2022-01-06 Impact factor: 10.668
Authors: Roman Schniepp; Anna Huppert; Julian Decker; Fabian Schenkel; Cornelia Schlick; Atal Rasoul; Marianne Dieterich; Thomas Brandt; Klaus Jahn; Max Wuehr Journal: J Neurol Date: 2021-03-13 Impact factor: 4.849
Authors: Guillermo Cano-Escalera; Manuel Graña; Jon Irazusta; Idoia Labayen; Ariadna Besga Journal: Int J Environ Res Public Health Date: 2022-02-16 Impact factor: 3.390
Authors: Taylor R Elliott; Susan Westneat; Shama D Karanth; Erin L Abner; Anna M Kucharska-Newton; Daniela C Moga Journal: BMC Geriatr Date: 2022-03-10 Impact factor: 3.921